Securities Law

Class Action Litigation Class Action Lawsuit Class Action Lawsuits Regulatory Compliance Securities Fraud Investor Rights Securities Class Action Lawsuit Investor Protection Securities Litigation

REGENXBIO Investors Face April 14 Deadline to Seek Lead Role in Securities Suit

Plaintiffs tie losses to FDA trial holds disclosed Jan. 28 after a reported tumor in a participant.

uniQure Investors Face April 13 Deadline in Securities Class Action Over FDA Setback

Investor Lawsuits Target Navan’s IPO Disclosures With Lead-Plaintiff Deadline on April 24

Plaintiff Firms Seek PayPal Investors to Lead Securities Class Action Before April 20 Deadline

Kyndryl Class Action Moves Forward as Investors Face April 13 Lead-Plaintiff Deadline

Robinhood’s Private-Markets Fund Drops 11% in NYSE Debut After $658 Million IPO

Richtech Robotics Hit With Securities Suits Over Microsoft Claims as April 3 Lead‑Plaintiff Deadline Nears

BellRing Investors Face March 23 Deadline To Seek Lead Role in Securities Suit

SEC Grants Conditional Section 16 Relief to Some FPI Insiders, Names Six Qualifying Jurisdictions

NuScale Faces Securities Class Action Over ENTRA1 Disclosures as Investors Eye Lead‑Plaintiff Bid

Investor Law Firms Rally uniQure Case as April 13 Lead-Plaintiff Deadline Nears

SEC Finalizes Rules Putting FPI Directors and Officers Under Section 16

SEC Unveils First Enforcement Manual Rewrite in Eight Years, Standardizing Wells and Settlements

U.S. Judge Blocks Binance Bid to Force Arbitration on Pre-2019 Claims

Ramaco Resources Investors Urged to Seek Lead Role in Securities Suit Before March 31 Deadline

Plaintiff Firms Urge Inovio Investors to Seek Lead Role in Securities Suit by April 7

Kyndryl Class Action Moves Forward With April 13 Lead-Plaintiff Deadline

Paysafe Investors Face April 7 Deadline in Securities Class Action Over Alleged Disclosure Failures

SEC Staff Reaffirms Tokenized Securities Fall Under Existing Federal Rules

Mereo BioPharma Investors Face April 6 Deadline in Lawsuits Over Failed Setrusumab Trials